IDEXX Laboratories, Inc.
IDXX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,897,504 | $3,660,953 | $3,367,324 | $3,215,360 |
| % Growth | 6.5% | 8.7% | 4.7% | – |
| Cost of Goods Sold | $1,518,577 | $1,470,983 | $1,362,986 | $1,325,928 |
| Gross Profit | $2,378,927 | $2,189,970 | $2,004,338 | $1,889,432 |
| % Margin | 61% | 59.8% | 59.5% | 58.8% |
| R&D Expenses | $219,792 | $190,951 | $254,820 | $161,009 |
| G&A Expenses | $442,291 | $335,825 | $326,248 | $309,660 |
| SG&A Expenses | $1,030,798 | $901,891 | $850,753 | $796,395 |
| Sales & Mktg Exp. | $588,507 | $566,066 | $524,505 | $486,735 |
| Other Operating Expenses | $0 | $0 | $2,200 | $1,464 |
| Operating Expenses | $1,250,590 | $1,092,842 | $1,105,573 | $957,404 |
| Operating Income | $1,128,337 | $1,097,128 | $898,765 | $932,028 |
| % Margin | 29% | 30% | 26.7% | 29% |
| Other Income/Exp. Net | -$18,506 | -$35,952 | -$38,793 | -$29,374 |
| Pre-Tax Income | $1,109,831 | $1,061,176 | $859,972 | $902,654 |
| Tax Expense | $221,964 | $216,134 | $180,883 | $157,810 |
| Net Income | $887,867 | $845,042 | $679,089 | $744,845 |
| % Margin | 22.8% | 23.1% | 20.2% | 23.2% |
| EPS | 10.77 | 10.17 | 8.12 | 8.74 |
| % Growth | 5.9% | 25.2% | -7.1% | – |
| EPS Diluted | 10.67 | 10.06 | 8.03 | 8.6 |
| Weighted Avg Shares Out | 82,467 | 83,066 | 83,623 | 85,200 |
| Weighted Avg Shares Out Dil | 83,246 | 83,978 | 84,600 | 86,572 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12,699 | $5,629 | $1,065 | $434 |
| Interest Expense | $31,205 | $41,581 | $39,858 | $29,808 |
| Depreciation & Amortization | $129,936 | $114,908 | $111,900 | $104,596 |
| EBITDA | $1,275,840 | $1,217,665 | $1,014,530 | $1,039,858 |
| % Margin | 32.7% | 33.3% | 30.1% | 32.3% |